Miraculins Executes Final Agreement to Acquire PREVU(TM) Skin Cholesterol Test – MarketWatch (press release)
posted on Aug 05 by preeclampsia - Google News in the Uncategorized categoryMiraculins Executes Final Agreement to Acquire PREVU(TM) Skin Cholesterol Test MarketWatch (press release) The Company's lead program, a suite of biomarkers for preeclampsia, is partnered with Inverness Medical Innovations (NYSE: IMA), one of the world's largest ... |



